Company intelligence / Profile preview

Rediscovery Life Sciences

Cambridge, Massachusetts, United Statescrunchbase.com ↗

Ownership: Private
Employees: ~10
Development stage: Phase 2

Overview

RLS advanced suramin sodium into Phase 2 clinical trials for acute kidney injury. The company’s data contributed to further development efforts after being acquired by PaxMedica for use in other indications such as African Sleeping Sickness. No additional programs or results are publicly disclosed.

Therapeutic areas: Nephrology
Modalities: Small molecules (notably repurposed drugs such as suramin sodium)Chemical drugs
Industry: Biotech

Drug pipeline

1 asset

suramin

Phase 2

Indications: Acute Kidney Injury

Beyond the preview

Go deeper on Rediscovery Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rediscovery Life Sciences.

Explore the full profile